Glaukos director Leana Wen sells 525 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Glaukos Corp director Leana Wen sold 525 shares of common stock on July 31, 2026 at $167.63 per share in a sale described as an open-market or private transaction. After the sale, she reports holding 21,092 shares, including 2,501 restricted stock units that are unvested or with deferred delivery. The transaction was not reported as made under a Rule 10b5-1 trading plan.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1 | 525 | $167.63 | $88K |
Footnotes (1)
- F1. Includes 2,501 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person.
Key Figures
Key Terms
restricted stock units financial
open market or private transaction financial
Reporting Person regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did director Leana Wen report for Glaukos (GKOS)?
Does Leana Wen’s Glaukos (GKOS) position include restricted stock units?
Was Leana Wen’s July 31, 2026 Glaukos (GKOS) sale under a Rule 10b5-1 plan?
What type of transaction code is used for Leana Wen’s Glaukos (GKOS) sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.